Current:Home > MyFDA approves first vaccine against chikungunya virus for people over 18-InfoLens
FDA approves first vaccine against chikungunya virus for people over 18
View Date:2024-12-23 11:54:11
The U.S. Food and Drug Administration on Thursday approved the first vaccine against chikungunya virus, a disease that is primarily transmitted to people through infected mosquito bites.
The vaccine, Ixchiq, was approved for people 18 years and older who are at an increased risk of exposure to the virus, in what officials said is an emerging global health threat, with at least 5 million cases reported during the past 15 years.
Experts said the highest risk of infection is in the tropical and subtropical regions of Africa, Southeast Asia, and parts of the Americas, where the virus-carrying mosquitoes are endemic. But chikungunya virus has spread elsewhere, causing more cases of the disease globally, officials said in a release.
"Infection with chikungunya virus can lead to severe disease and prolonged health problems, particularly for older adults and individuals with underlying medical conditions," said Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research. "Today's approval addresses an unmet medical need and is an important advancement in the prevention of a potentially debilitating disease with limited treatment options."
Officials said Valneva, a French bio-tech company, was given "accelerated approval" by the FDA to create the Ixchiq vaccine due to the seriousness and life-threatening conditions caused by the disease.
'People need to be on their toes':Mosquito populations surge in parts of California after tropical storms and triple-digit heat
Chikungunya symptoms
The most common symptoms of chikungunya are fever and debilitating joint pain, which may persist for months or years, according to the FDA. Other symptoms include rash, headache, and muscle pain.
The FDA also said that chikungunya virus is also severe and potentially fatal to newborn babies from pregnant individuals at delivery. Doctors recommend those infected to rest, drink fluids, and take over-the-counter medicine to treat pain and fever.
Today, people infected with chikungunya can receive a single-dose injection into the muscle to treat the sickness. The vaccine contains a live and weakened version of the virus that may cause people to experience symptoms similar to the disease, officials said.
The FDA said the Ixchiq vaccine was evaluated in two clinical studies in North America with about 3,500 people 18 years or older, receiving a dose of the medicine and about 1,000 participants who received a placebo.
Officials said the most commonly reported side effects of the vaccine were headache, fatigue, muscle pain, joint pain, fever, nausea, and tenderness at the injection site. Experts said severe chikungunya-like reactions that prevent daily activity are uncommon, with only 1.6% of vaccine recipients and none of the placebo recipients requiring medical intervention.
How to get rid of mosquitoes:Tips to keep the pests away, control them in your house
Two vaccine recipients with severe adverse reactions were hospitalized, officials said. Some patients reported reactions that lasted for at least 30 days. In one study, most individuals were found to have the virus in their bloodstream one week after vaccination; the vaccine virus was undetected two weeks following inoculation, according to the FDA.
The vaccine includes caution labels about possible severe reactions, including a warning that says experts are unsure if the virus can be transmitted from pregnant people to newborns.
The FDA is requiring researchers to conduct a postmarket study of the medicine to assess potential risks.
veryGood! (7)
Related
- Subway rider who helped restrain man in NYC chokehold death says he wanted ex-Marine to ‘let go’
- 14-year-old boy rescued after falling 70 feet from Grand Canyon cliff
- 3-year-old dies aboard migrant bus headed from Texas to Chicago
- How to watch Hip Hop 50 Live at Yankee Stadium with Snoop Dogg, Ice Cube and Run-D.M.C.
- Shaun White Reveals How He and Fiancée Nina Dobrev Overcome Struggles in Their Relationship
- Top lawyer at Fox Corp. to step down after overseeing $787M settlement in Dominion defamation case
- Camp Lejeune Marine vets, families still wait for promised settlements over possible toxic water exposure
- 50 essential hip-hop songs to celebrate 50 years: Grandmaster Flash, Jay-Z, Outkast, more
- Lions QB Jared Goff, despite 5 interceptions, dared to become cold-blooded
- 4 arrested after a shooting that wounded a Minneapolis police officer
Ranking
- Sydney Sweeney Slams Women Empowerment in the Industry as Being Fake
- Rescued walrus calf that was receiving cuddles as part of his care in Alaska dies
- Jennifer Hudson's 14-Year-Old Son David Looks All Grown Up in Birthday Video
- Hawaii trauma surgeon says Maui hospital is holding up really well amid wildfires
- 'Yellowstone' premiere: Record ratings, Rip's ride and Billy Klapper's tribute
- Zoom's updated TOS prompted concerns about AI and privacy. Can the two go hand-in-hand?
- Toyota recalls roughly 168,000 vehicles over fire risk
- How an obscure law about government secrets known as CIPA could shape the Trump documents trial
Recommendation
-
John Krasinski named People's Sexiest Man Alive for 2024
-
Johnny Hardwick, voice actor who played Dale Gribble on King of the Hill, dies at 64
-
Lenny Wilkens tells how Magic Johnson incited Michael Jordan during lazy Dream Team practice
-
Seattle Mariners fan surprises Félix Hernández at team's Hall of Fame ceremony
-
Fate of Netflix Series America’s Sweethearts: Dallas Cowboys Cheerleaders Revealed
-
Former foster children win $7M settlement after alleging state turned blind eye to abuse
-
How fixing up an old Mustang helped one ALS patient find joy through friendship
-
School choice debate not over as Nevada’s governor has a plan to fund private school scholarships